Nebulizer Use for Dogs and Cats - Veterinary Partner - VIN
Dosing | ARIKAYCE® (amikacin liposome inhalation suspension)
A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram‐Negative Ventilator‐Associated Pneumonia: IASIS Trial | Semantic Scholar
PDF) Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials
A comparative study between effect of combined intravenous and nebulized amikacin versus intravenous amikacin alone in mechanically ventilated patients with ventilator-associated pneumonia (VAP) | Ain-Shams Journal of Anesthesiology | Full Text
Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects | Intensive Care Medicine
Aerosolized Antibiotics | Respiratory Care
MAC Resources | ARIKAYCE® (amikacin liposome inhalation suspension)
The Unfulfilled Promise of Inhaled Therapy in Ventilator-Associated Infections: Where Do We Go from Here? | Journal of Aerosol Medicine and Pulmonary Drug Delivery
Mean cumulative systemic absorption of amikacin as a function of time.... | Download Scientific Diagram
Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure - ScienceDirect
Delivery Efficacy of a Vibrating Mesh Nebulizer and a Jet Nebulizer under Different Configurations | Journal of Aerosol Medicine and Pulmonary Drug Delivery
Diagram of the nebulization setup | Download Scientific Diagram
Antibiotics | Free Full-Text | Pharmacokinetic Characteristics of Nebulized Colistimethate Sodium Using Two Different Types of Nebulizers in Critically Ill Patients with Ventilator-Associated Respiratory Infections
Oral Inhaled Medications—Beyond Bronchodilators
Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial - The Lancet Infectious Diseases
Frontiers | Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages
Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials | Scientific Reports
Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease | Antimicrobial Agents and Chemotherapy
Frontiers | Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages
Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia | NEJM
Dosing | ARIKAYCE® (amikacin liposome inhalation suspension)
PARI Pharma's eFlow® Technology device, LAMIRA™, approved as the only nebulizer system to deliver Insmed's ARIKAYCE® (amikacin liposome inhalation suspension)
Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia – topic of research paper in Medical engineering. Download scholarly article PDF and read for
Is ARIKAYCE® Right for You? | ARIKAYCE® (amikacin liposome inhalation suspension)
